Sparkle of Hope Gala Chair OLIVIER BOGILLOT Head North America General Medicines Sanofi
Sparkle of Hope Gala Chair
ROBERT A. BRADWAY Chairman and CEO Amgen
Robert A. Bradway is Amgen’s chairman and chief executive officer. He became chairman in January 2013 and chief executive officer in May 2012. Bradway served as the
As Head of North America General Medicines, Olivier Bogillot leads the business unit responsible for serving the Diabetes, Transplant and Established Products communities.
company’s president and chief operating officer from May 2010 to May 2012, and was appointed to the Amgen Board of Directors in October 2011. He joined the company in 2006 as vice president, Operations Strategy, and served as executive vice president and chief financial officer from April 2007 to May 2010. Prior to joining Amgen, Bradway was a managing director at Morgan Stanley in London where, beginning in 2001, he had responsibility for the firm’s banking department and corporate finance activities in Europe. He joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990. Bradway is a member of the board of directors of The Boeing Company, chairing its Governance and Public Policy Committee and serving on its Compensation Committee. He also serves as a board member of the W. M. Keck Foundation and the Pharmaceutical Research and Manufacturers of America. Bradway also serves on the board of trustees of the University of Southern California, he is an Emeritus Director of the CEO Roundtable on Cancer, and he is a member of the American Heart Association CEO Roundtable. Bradway holds a bachelor’s degree in biology from Amherst College and a master’s degree in business administration from Harvard University.
Prior to this role, Olivier was the President of Sanofi France where he led the Strategic Committee and the Country Council of Sanofi France, coordinating all the activities of the French subsidiary and representing the Group to French Authorities and professional organizations. He joined Sanofi in 2015, and has held various positions within the company, including as Executive Director of Global Policy based in the U.S. and Chief of Staff to the CEO. Olivier held key roles in market access at Merck KGaA, Amgen and Bristol-Myers Squibb before being appointed Chief of Staff to the Director at the Greater Paris Regional Health Agency in 2009. He subsequently joined the Presidency of the French Republic in 2011, as advisor for health, dependency, and social policies. He holds a PhD in Economics from the University of Lyon I, a master’s degree in Health Economics and Public Health, and a degree in Molecular Biology and Physiology. He sits on the Board of Directors of Les Entreprises du Médicament (Leem), the Board of Directors of Clariane (CLARI), and chairs the French Federation of Health Industries (FEFIS).
Made with FlippingBook - Online Brochure Maker